Buy 5-MeO-DiBF for sale online from USA vendor

Table of Contents

1. Introduction
2. Chemistry of 5-MeO-DiBF
3. Pharmacology
   • Mechanism of Action
   • Comparative Potency
4. Subjective Effects
   • Physical Effects
   • Visual Effects
   • Cognitive Effects
   • Auditory Effects
5. Toxicity and Harm Potential
   • Limited Research
   • Anecdotal Reports
   • Harm Reduction
6. Tolerance, Addiction, and Interactions
   • Tolerance
   • Addiction Potential
   • Dangerous Interactions
7. Legal Status
8. Dosage Guidelines for 5-MeO-DiBF
9. FAQ

5-Methoxy-N,N-diisopropylbenzofuranethylamine: An Introduction to 5-MeO-DiBF

Introduction

5-Methoxy-N,N-diisopropylbenzofuranethylamine, commonly referred to as 5-MeO-DiBF, stands as a novel psychedelic compound belonging to the benzofuran class. Upon administration, it elicits psychedelic and stimulating effects akin to its structural relative, 5-MeO-DiPT.

Historical Background

Before its emergence in September 2015 within the online research chemical market, there exists scant documentation regarding the human utilization of this compound. Its introduction to the market marks its initial foray into human recreational use and exploration.

Pharmacological Properties

Despite its increasing prevalence, comprehensive knowledge concerning the pharmacological properties, metabolic pathways, and toxicity of 5-MeO-DiBF remains limited. The compound's novelty underscores the critical need for further research to elucidate its effects and potential risks.

Harm Reduction

In light of its nascent presence and uncertain toxicity profile, it is strongly recommended that individuals exercise caution and adhere to harm reduction practices when engaging with 5-MeO-DiBF. Such measures include dosage moderation, informed consent, and access to appropriate support resources.

Chemistry of 5-MeO-DiBF

Structure

5-MeO-DiBF, or 5-methoxy-N,N-diisopropylbenzofuranethylamine, represents a synthetic heterocyclic alkaloid molecule categorized within the benzofuran class. Benzofuran, characterized by its bicyclic structure resulting from the fusion of a benzene ring and a furan ring, encompasses a five-member aromatic ring with an oxygen substituent.

Composition

At its core, 5-MeO-DiBF comprises a benzofuran group linked at R3 to an amino group via an ethyl side chain. Additionally, it features a methoxy (MeO) functional group (CH3O−) situated at R5 of the benzofuran heterocycle, alongside two isopropyl chains bound to the terminal amine RN of its tryptamine backbone (DiBF).

Structural Relationship

The benzofuran group inherent in 5-MeO-DiBF bears structural resemblance to the indole found in tryptamines. Notably, benzofuran harbors an oxygen group analogous to the nitrogen present in indole. Consequently, 5-MeO-DiBF shares structural kinship with the psychedelic tryptamine 5-MeO-DiPT, effectively serving as the benzofuran analogue of 5-MeO-DiPT.

Pharmacology

Mechanism of Action

5-MeO-DiBF is speculated to function as a 5-HT2A partial agonist, exerting its psychedelic effects through interactions with the 5-HT1A and 5-HT2 family of serotonin receptors. However, the precise mechanisms underlying these interactions and their resultant psychedelic experiences remain incompletely understood.

Comparative Potency

Relative to 5-MeO-DiPT, 5-MeO-DiBF exhibits diminished potency as a serotonin agonist. While demonstrating enhanced activity at 5-HT1A receptors, its primary effects are observed within the 5-HT2 receptor family.

Subjective Effects

Physical Effects

• Stimulation
• Spontaneous physical sensations
• Increased heart rate
• Muscle spasms
• Mild nausea
• Perception of bodily lightness
• Pupil dilation
• Tactile enhancement
• Suppression of temperature regulation

Visual Effects

• Enhancements: Color, pattern recognition, visual acuity
• Distortions: Drifting, color shifting, tracers

Cognitive Effects

• Insightful headspace
• Analysis enhancement
• Conceptual thinking
• Emotion enhancement
• Increased libido
• Enhanced music appreciation
• Memory suppression
• Ego death
• Novelty enhancement
• Personal bias suppression
• Rejuvenation
• Thought acceleration
• Thought connectivity
• Time distortion
• Increased wakefulness

Auditory Effects

• Auditory enhancement
• Auditory distortion
• Auditory hallucination

Toxicity and Harm Potential

Limited Research

Scientific exploration regarding the toxicity and long-term health implications of 5-MeO-DiBF remains scarce. Its status as a research chemical, coupled with minimal human usage history, complicates comprehensive assessment of its toxicological profile.

Anecdotal Reports

Anecdotal evidence suggests minimal negative health effects associated with cautious, low to moderate dosage usage. However, independent research is imperative to ascertain the safety of combining 5-MeO-DiBF with other substances.

Harm Reduction

In light of its uncertain toxicity profile, adherence to harm reduction practices is strongly advocated when engaging with 5-MeO-DiBF.

Tolerance, Addiction, and Interactions

Tolerance

Immediate tolerance accrual post-ingestion necessitates several days for reduction to half, with complete tolerance reversal typically occurring within seven days.

Addiction Potential

Notably non-habit-forming, 5-MeO-DiBF may even diminish desire for continued usage over time.

Dangerous Interactions

Caution is warranted when combining 5-MeO-DiBF with substances such as lithium, cannabis, stimulants, and tramadol, as adverse reactions, including psychosis and seizures, may manifest.

Legal Status

Regulatory Landscape

The legal status of 5-MeO-DiBF varies globally, with its legality subject to regional legislation. While accessible via online research chemical vendors, possession may not guarantee immunity from legal repercussions, underscoring the necessity for individual awareness of local statutes.

Dosage Guidelines for 5-MeO-DiBF

Threshold

• Threshold Dose: 20 mg

Light

• Light Dose Range: 50 - 80 mg

Common

• Common Dose Range: 80 - 110 mg

Strong

• Strong Dose Range: 110 - 140 mg

Heavy

• Heavy Dose: 140 mg and above

FAQ (Frequently Asked Questions)

1. What is 5-MeO-DiBF?

5-MeO-DiBF, or 5-methoxy-N,N-diisopropylbenzofuranethylamine, is a synthetic heterocyclic alkaloid molecule belonging to the benzofuran class. It exhibits psychedelic and stimulating effects upon administration.

2. How does 5-MeO-DiBF compare to other psychedelics?

5-MeO-DiBF is structurally related to 5-MeO-DiPT and shares similarities with other tryptamines. However, its benzofuran structure distinguishes it from classic tryptamines like psilocybin and DMT.

3. What are the recommended dosage ranges for 5-MeO-DiBF?

• Threshold Dose: 20 mg
• Light Dose Range: 50 - 80 mg
• Common Dose Range: 80 - 110 mg
• Strong Dose Range: 110 - 140 mg
• Heavy Dose: 140 mg and above

4. Are there any known dangerous interactions with 5-MeO-DiBF?

Caution should be exercised when combining 5-MeO-DiBF with substances like lithium, cannabis, stimulants, and tramadol, as they may potentiate adverse reactions such as psychosis and seizures.

5. Is 5-MeO-DiBF habit-forming?

No, 5-MeO-DiBF is not habit-forming, and its usage may even diminish over time. However, immediate tolerance develops post-ingestion, necessitating several days for tolerance reduction.

6. What is the legal status of 5-MeO-DiBF?

The legal status of 5-MeO-DiBF varies globally, with its legality subject to regional legislation. It may be categorized as a controlled substance in some jurisdictions.

7. How can harm reduction be practiced when using 5-MeO-DiBF?

Harm reduction practices include dosage moderation, informed consent, and avoidance of combining 5-MeO-DiBF with other substances without thorough research into potential interactions.

8. Is there research on the long-term health effects of 5-MeO-DiBF?

Scientific exploration on the toxicity and long-term health implications of 5-MeO-DiBF is limited. Anecdotal reports suggest minimal negative health effects at low to moderate doses, but further research is needed for comprehensive assessment.